|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
ImClone Systems (2008)
Loxo_Oncology_(2019)
Avid_Radiopharmaceuticals_(2010)
Dermira_(2020)
|
|
gptkbp:CEO
|
gptkb:David_A._Ricks
|
|
gptkbp:employees
|
over 35,000
|
|
gptkbp:founded
|
1876
|
|
gptkbp:founder
|
gptkb:Eli_Lilly
|
|
gptkbp:headquarters
|
gptkb:Indianapolis,_Indiana
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Eli Lilly
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:market
|
approximately $200 billion (2021)
|
|
gptkbp:notableFeature
|
gptkb:Basaglar
Cymbalta
Humalog
Zyprexa
Trulicity
Emgality
Olumiant
Taltz
Verzenio
Forteo
|
|
gptkbp:partnerships
|
gptkb:Incyte_Corporation
gptkb:Boehringer_Ingelheim
gptkb:Eisai_Co.,_Ltd.
gptkb:Amgen
|
|
gptkbp:philanthropy
|
gptkb:Lilly_Endowment
gptkb:Lilly_Foundation
gptkb:Lilly_Global_Health
Lilly Diabetes
|
|
gptkbp:products
|
insulin
antidepressants
oncology drugs
|
|
gptkbp:research_focus
|
diabetes
cancer
neuroscience
immunology
|
|
gptkbp:revenue
|
$24.5 billion (2020)
|
|
gptkbp:stockExchange
|
gptkb:LLY
|
|
gptkbp:subsidiary
|
gptkb:Lilly_USA
ImClone Systems
|